Analyses / AVGO
Semiconductor leader facing valuation compression amid AI-slowdown chatter; strong FCF and dividends offset elevated multiples.
A free account reveals AVGO's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Strong revenue (24.4% YoY) and EPS growth (20.6% YoY, 46.6% 5-year CAGR) reflect broadening AI/cloud exposure beyond hyperscalers. 67.9% gross margin and 39.9% operating margin show pricing power. Dividend yield 1.88% + 48% payout ratio sustainable. Down 30% from 52-week high ($495) offers technical entry for long-term thesis.
▼ Bear Case
Forward P/E 74.5x and P/S 27.0x extreme for semiconductor cycle—pricing assumes uninterrupted AI ramp. EV/EBITDA 65.2x and price-to-FCF 64.0x unsustainably high if growth slows or cloud capex moderates. Insider selling (349 sells vs. 15 buys, net -3.5M shares) suggests executive caution. AI-slowdown headlines risk multiple compression.
Valuation
Overvalued on absolute multiples; fair on growth-adjusted basis if AI thesis holds. — score 42/100
Forward P/E 74.5x and EV/EBITDA 65.2x are in the 80th+ percentile for semiconductor sector, implying AI upside is fully priced and leaves no margin for execution miss. PEG ratio unavailable, but 24.4% revenue growth against 45x trailing P/E suggests premium justified only if growth sustains 20%+ YoY for 3+ years. Price-to-FCF 64.0x and P/S 27.0x also stretched. Modest current decline (30% from peak) has not corrected multiples proportionally; likely needs further compression or earnings re-acceleration.
Technical Levels
Support · $330.00 (200-day MA proxy; technical floor) · $310.00 (Stop-loss; clear break signals cascade risk) · $289.96 (52-week low; capitulation level)
Resistance · $361.99 (Previous close; immediate near-term cap) · $380.00 (3-month resistance; reclaim target) · $420.00 (2024 highs (pre-correction); bull case)
RSI: Not available
Financial Health
Score 74/100. Strong liquidity ratios and net profitability. Dividend well-covered by earnings. Debt and interest-coverage data unavailable; large market cap and cash-generative model suggest conservative leverage, but cannot verify without balance-sheet detail. Risk lies in sustaining profitability if capex/AI thesis disappointments occur.
Catalysts
| Q1 FY2025 Earnings (likely late Jan 2025) | 4-8 weeks | high |
| Cloud hyperscaler capex guidance for 2025 (shared earnings calls or investor day) | 6-12 weeks | high |
| AI-slowdown narrative resolution (confirm or deny demand moderation) | Immediate-4 weeks | high |
| Dividend increase announcement (if maintained at current trajectory) | 3-6 months | medium |
| Insider buying resumption (offset recent selling trend) | 6+ months | medium |
Risk Flags
See AVGO's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock AVGO free →Recent News
- Broadcom (NASDAQ:AVGO): Dividend Quality and Growth for Income InvestorsChartMill
- Wall Street Sells the AI-Pause Weekend as Brent Punches Through $106 and the Ten-Year Cracks 5% for the First Time Since 2023ChartMill
- Chip Stocks Sink on AI Slowdown Calls, But Analysts Doubt a Crash Is NearYahoo
- AI Slowdown Debate Splits Tech CEOs: Nvidia, Broadcom Dismiss Any Threat While Elon Musk Calls For Peer Review SystemYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full AVGO analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
AVGO FAQ
Is AVGO a buy right now?
Broadcom Inc's current read is a Growth with Dividend; Post-Correction Valuation Test setup with 65 confidence over a 6-12 months horizon. Valuation: Overvalued on absolute multiples; fair on growth-adjusted basis if AI thesis holds.. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is AVGO overvalued?
Overvalued on absolute multiples; fair on growth-adjusted basis if AI thesis holds. (valuation score 42/100). Forward P/E 74.5x and EV/EBITDA 65.2x are in the 80th+ percentile for semiconductor sector, implying AI upside is fully priced and leaves no margin for execution miss. PEG ratio unavailable, but 24.4% revenue growth against 45x trailing P/E suggests premium justified only if growth sustains 20%+ YoY for 3+ years. Price-to-FCF 64.0x and P/S 27.0x also stretched. Modest current decline (30% from peak) has not corrected multiples proportionally; likely needs further compression or earnings re-acceleration.
What are the risks of buying AVGO?
Forward P/E 74.5x and P/S 27.0x extreme for semiconductor cycle—pricing assumes uninterrupted AI ramp. EV/EBITDA 65.2x and price-to-FCF 64.0x unsustainably high if growth slows or cloud capex moderates. Insider selling (349 sells vs. 15 buys, net -3.5M shares) suggests executive caution. AI-slowdown headlines risk multiple compression.